Home Cart 0 Sign in  
X

[ CAS No. 872-85-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 872-85-5
Chemical Structure| 872-85-5
Chemical Structure| 872-85-5
Structure of 872-85-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 872-85-5 ]

Related Doc. of [ 872-85-5 ]

Alternatived Products of [ 872-85-5 ]

Product Details of [ 872-85-5 ]

CAS No. :872-85-5 MDL No. :MFCD00006425
Formula : C6H5NO Boiling Point : -
Linear Structure Formula :- InChI Key :BGUWFUQJCDRPTL-UHFFFAOYSA-N
M.W : 107.11 Pubchem ID :13389
Synonyms :

Calculated chemistry of [ 872-85-5 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.62
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.65 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.95
Log Po/w (XLOGP3) : 0.43
Log Po/w (WLOGP) : 0.89
Log Po/w (MLOGP) : -0.23
Log Po/w (SILICOS-IT) : 1.55
Consensus Log Po/w : 0.72

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.26
Solubility : 5.83 mg/ml ; 0.0545 mol/l
Class : Very soluble
Log S (Ali) : -0.63
Solubility : 25.3 mg/ml ; 0.236 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.91
Solubility : 1.33 mg/ml ; 0.0124 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 872-85-5 ]

Signal Word:Warning Class:
Precautionary Statements:P280-P305+P351+P338-P337+P313 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 872-85-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 872-85-5 ]
  • Downstream synthetic route of [ 872-85-5 ]

[ 872-85-5 ] Synthesis Path-Upstream   1~36

  • 1
  • [ 110-89-4 ]
  • [ 872-85-5 ]
  • [ 84228-93-3 ]
YieldReaction ConditionsOperation in experiment
84% With malonic acid In pyridine A.
Preparation of 3-(4-pyridyl)acrylic acid
4-Pyridinecarboxaldehyde (18.96 g, 0.177 mol) and malonic acid (55.3 g, 0.53 mol) were placed in 200 ml of pyridine.
Piperidine (5.25 ml, 0.053 mol) was added and the reaction was refluxed for 6 hours.
The reaction mixture was cooled in an ice bath and then the white solid was filtered off and rinsed with ether and dried to afford 20.1 g of the subtitle compound.
Concentration of the filtrate and then filtration and rinsing with ether resulted in recovery of another 2.2 g of product (84percent total yield).
Reference: [1] Patent: EP846687, 1998, A1,
[2] Patent: US5972972, 1999, A,
[3] Patent: US5618939, 1997, A,
  • 2
  • [ 872-85-5 ]
  • [ 141-82-2 ]
  • [ 84228-93-3 ]
YieldReaction ConditionsOperation in experiment
6.9 g at 80 - 115℃; for 4 h; pyridine-4-carbaldehyde (5 g, 0.047 mol), malonic acid (2.2 g (0.094 mol)), pyridine (30 mL), and piperidine (850 ul, 8.5 mmol) were mixed well, heated to 80-85° C. for 1 h and finally refluxed (110-115° C.) for an additional 3 h.
The reaction mixture was poured into water and acidified with concentrated HCl.
The precipitate obtained was filtered, and washed with cold water repeatedly.
The residue was dissolved in NaOH, diluted, again acidified, the precipitate was collected washed with cold water and dried under high vacuum over P2O5 and used without further purifications. Yield=6.9 g.
Reference: [1] Russian Journal of General Chemistry, 2005, vol. 75, # 7, p. 1113 - 1124
[2] Journal of Organic Chemistry, 1955, vol. 20, p. 1785,1790
[3] Synthesis, 1992, # 4, p. 395 - 398
[4] Heterocycles, 1994, vol. 37, # 3, p. 1495 - 1502
[5] Journal of Molecular Structure, 2015, vol. 1090, p. 25 - 33
[6] MedChemComm, 2015, vol. 6, # 6, p. 1036 - 1042
[7] Patent: US2016/168100, 2016, A1, . Location in patent: Paragraph 0374
  • 3
  • [ 872-85-5 ]
  • [ 84228-93-3 ]
Reference: [1] Patent: US6538007, 2003, B1,
[2] Patent: US5463067, 1995, A,
[3] Patent: EP1104754, 2001, A1,
[4] Patent: US2004/92598, 2004, A1,
[5] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 313 - 319
  • 4
  • [ 108-89-4 ]
  • [ 872-85-5 ]
  • [ 13362-78-2 ]
YieldReaction ConditionsOperation in experiment
49% With acetic acid; lithium diisopropyl amide In tetrahydrofuran at -70℃; for 24 h; Darkness; Reflux 400μL (4.12mmol) of 4-picoline reacted with 3.0mL (4.32mmol) of LDA in THF (5mL) at −70°C. In the absence of light, 465mL (4.12mmol) of 4-piridincarboxyaldehyde was dropwise added with continuous stirring. After 24h of reflux in the presence of 10mL of acetic acid, the reaction mixture led to a yellow solution, from which a pale-yellow solid was separated by rotatory evaporation. The solid was purified employing column chromatography in analogous conditions to the ones previously mentioned (368mg, 49percent). 1H RMN (400MHz, CDCl3, δ): 8.62 (d, J=4Hz, 4H, Ar−H), 7.61 (d, J=4Hz, 4H, Ar−H), 7.55 (s, 2H, −CH=CH−).
Reference: [1] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2017, vol. 183, p. 45 - 52
[2] Journal of the American Chemical Society, 1948, vol. 70, p. 2330,2333
  • 5
  • [ 872-85-5 ]
  • [ 74-89-5 ]
  • [ 6971-44-4 ]
Reference: [1] Patent: WO2006/80954, 2006, A1, . Location in patent: Page/Page column 80
  • 6
  • [ 872-85-5 ]
  • [ 593-51-1 ]
  • [ 6971-44-4 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1987, vol. 320, # 7, p. 647 - 654
[2] Journal of Medicinal Chemistry, 2017, vol. 60, # 3, p. 972 - 986
  • 7
  • [ 872-85-5 ]
  • [ 6971-44-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 11, p. 1892 - 1903
[2] CrystEngComm, 2011, vol. 13, # 22, p. 6817 - 6826
  • 8
  • [ 872-85-5 ]
  • [ 94170-15-7 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1958, vol. 6, p. 615,617
  • 9
  • [ 872-85-5 ]
  • [ 1099-45-2 ]
  • [ 5337-79-1 ]
Reference: [1] Patent: US4638000, 1987, A,
  • 10
  • [ 872-85-5 ]
  • [ 141-82-2 ]
  • [ 5337-79-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1989, vol. 24, p. 65 - 72
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 19, p. 8140 - 8151
  • 11
  • [ 872-85-5 ]
  • [ 67-56-1 ]
  • [ 2459-09-8 ]
YieldReaction ConditionsOperation in experiment
89% With potassium carbonate In water at 20℃; for 2 h; General procedure: A mixture of bromine chloride resin and K2CO3 in MeOH–H2O (8:2) 3 mL was placed in a round-bottom flask fitted with amagnetic stirrer. To this, the aldehyde (1 mmol, 1 equiv) was added dropwise, and the reaction mixture stirred at r.t. The progress of the reaction was monitored by TLC. After completionof the reaction the mixture was filtered, and the filtrate was extracted with Et2O. The ether layer was washed with H2O, brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column chromatography, if required, over silicagel (60–120 mesh) using a mixture of PE and EtOAc (9:1) as eluent.
83% at 20℃; for 1 h; General procedure: To a solution of alcohol(1 mmol) in a mixture of MeCN and MeOH (5:1, 2.4 mL) was added TsNBr2(2.5 mmol) and K2CO3 (5 mmol) and stirred at room temperature. After completion of the reaction (TLC) sodium thiosulfate was added and the reaction mixture was stirred for 10 min. The reaction mixture was extracted indiethyl ether and hexane (1:1), dried, (Na2SO4) and concentrated. Purification of the crude product by flash chromatography on silica gel (230–400 mesh)with petroleum ether–EtOAc as eluent gave the pure product.In case of ester synthesis from aldehydes, reaction was carried out using1.5 mmol of TsNBr2 and 2 mmol of K2CO3 for 1 mmol of substrate. For methylester synthesis, methanol (5 mL) was used as a solvent and for other alkyl ester synthesis 5:1 mixture of MeCN–ROH (2.4 mL) was used as the reaction medium. Work-up procedure remains the same.
Reference: [1] Synthesis, 2010, # 2, p. 276 - 282
[2] Synlett, 2016, vol. 27, # 9, p. 1344 - 1348
[3] Tetrahedron Letters, 2014, vol. 55, # 39, p. 5358 - 5360
[4] Synthetic Communications, 2010, vol. 40, # 2, p. 186 - 195
[5] Synthesis, 2009, # 9, p. 1578 - 1581
[6] Organic Letters, 2018, vol. 20, # 17, p. 5172 - 5176
[7] European Journal of Medicinal Chemistry, 2002, vol. 37, # 2, p. 163 - 170
[8] Green Chemistry, 2014, vol. 16, # 4, p. 2164 - 2173
[9] Chemical Science, 2016, vol. 7, # 7, p. 4428 - 4434
  • 12
  • [ 872-85-5 ]
  • [ 153813-70-8 ]
Reference: [1] Acta Chemica Scandinavica, 1999, vol. 53, # 2, p. 141 - 144
  • 13
  • [ 872-85-5 ]
  • [ 33972-97-3 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1958, vol. 6, p. 615,617
  • 14
  • [ 872-85-5 ]
  • [ 71879-55-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 3, p. 529 - 538
[2] Patent: WO2014/131855, 2014, A1,
  • 15
  • [ 872-85-5 ]
  • [ 4916-57-8 ]
Reference: [1] Heterocycles, 1990, vol. 31, # 7, p. 1271 - 1274
[2] Journal of the American Chemical Society, 1948, vol. 70, p. 2330,2333
  • 16
  • [ 872-85-5 ]
  • [ 3515-49-9 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 163,166
[2] Patent: US2011/152243, 2011, A1,
  • 17
  • [ 872-85-5 ]
  • [ 120-72-9 ]
  • [ 3515-49-9 ]
Reference: [1] Journal of Organic Chemistry, 1958, vol. 23, p. 1453
  • 18
  • [ 872-85-5 ]
  • [ 70201-43-3 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 3, p. 397 - 406
  • 19
  • [ 872-85-5 ]
  • [ 33403-97-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 17, p. 6040 - 6049
[2] Patent: US2013/203754, 2013, A1,
  • 20
  • [ 872-85-5 ]
  • [ 87-41-2 ]
  • [ 67592-40-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 12, p. 2310 - 2323
[2] European Journal of Medicinal Chemistry, 2010, vol. 45, # 8, p. 3504 - 3510
[3] Archiv der Pharmazie, 2012, vol. 345, # 4, p. 287 - 293
[4] Chinese Chemical Letters, 2010, vol. 21, # 9, p. 1071 - 1074
  • 21
  • [ 872-85-5 ]
  • [ 2107-69-9 ]
  • [ 4803-74-1 ]
YieldReaction ConditionsOperation in experiment
98% With potassium hydroxide In water at 25 - 30℃; for 3 h; Example 1: Process for preparation of 5,6-dimethoxy-2-(4-pyridylmethylene)-l- indanone of formula IVTo a 1 liter round bottom flask equipped with a mechanical stirrer, thermometer pocket, addition funnel and a condenser, charged demineralized water (250ml), 5,6- dimethoxy-l-indanone (25g) and pyridine-4-carboxaldehyde (19.5g). The reaction mixture was stirred for 5 minutes at a temperature of 25°C to 30°C. To the reaction mixture then charged a solution of potassium hydroxide (5.2g) dissolved in demineralized water (125ml) slowly over period of 2 hours at a temperature of 25 °C to 30°C. The reaction mixture was further maintained at a temperature of 25°C to 30°C for 1 hour to obtain the product, 5,6-dimethoxy-2-(4-pyridylmethylene)-l- indanone. The product obtained was then filtered and washed with demineralized water. Dry the product under vacuum at a temperature of 50°C to 55°C for 10 hours. Yield: 98percentPurity: 99.71percent
95.8%
Stage #1: With toluene-4-sulfonic acid In toluene for 6 h; Heating / reflux
Stage #2: With sodium carbonate In water for 0.5 - 1 h;
5, 6 Dimethoxy indanone (100 grams), Pyridine-4-carboxaldehyde (78.0 grams) and p-toluene sulfonic acid (138.4 grams) were suspended in toluene (1250 ml) and heated to reflux using water separator for 6 hours. The resulting mass was cooled to 25-40° C. and the solid was filtered off under suction. Further the wet solid was suspended in aqueous 10percent sodium carbonate solution (1200 ml) and stirred for 30-60 minutes. The resulting pale yellow precipitate solid was filtered off under suction, washed with water (1000 ml) and dried at a temperature of 80° C. to afford 5,6 Dimethoxy-2-(pyridin-4yl)-methylene-indan-lone (Weight: 140 grams, 95.8percent).
Reference: [1] Patent: WO2012/131540, 2012, A1, . Location in patent: Page/Page column 16
[2] Patent: US2004/143121, 2004, A1, . Location in patent: Page 3
[3] Patent: WO2004/82685, 2004, A1, . Location in patent: Page/Page column 9
[4] European Journal of Medicinal Chemistry, 2011, vol. 46, # 11, p. 5694 - 5697
[5] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 23, p. 7029 - 7035,7
[6] Journal of Enzyme Inhibition and Medicinal Chemistry, 2013, vol. 28, # 3, p. 644 - 650
[7] Journal of Enzyme Inhibition and Medicinal Chemistry, 2014, vol. 28, # 3, p. 644 - 650
  • 22
  • [ 872-85-5 ]
  • [ 2747-08-2 ]
  • [ 4803-74-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2010, vol. 58, # 9, p. 1157 - 1160
  • 23
  • [ 872-85-5 ]
  • [ 2747-08-2 ]
  • [ 4803-74-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2010, vol. 58, # 9, p. 1157 - 1160
  • 24
  • [ 586-95-8 ]
  • [ 75-91-2 ]
  • [ 872-85-5 ]
  • [ 81660-73-3 ]
Reference: [1] Journal of Organic Chemistry, 1996, vol. 61, # 4, p. 1467 - 1472
  • 25
  • [ 872-85-5 ]
  • [ 138517-18-7 ]
  • [ 73564-69-9 ]
Reference: [1] Journal of Organic Chemistry, 1992, vol. 57, # 5, p. 1622 - 1625
  • 26
  • [ 872-85-5 ]
  • [ 73564-69-9 ]
Reference: [1] Chemistry - A European Journal, 2011, vol. 17, # 25, p. 7032 - 7040
  • 27
  • [ 872-85-5 ]
  • [ 109-97-7 ]
  • [ 123-08-0 ]
  • [ 51094-17-8 ]
  • [ 127822-97-3 ]
  • [ 127801-02-9 ]
  • [ 16834-13-2 ]
Reference: [1] Dyes and Pigments, 2010, vol. 84, # 1, p. 140 - 147
  • 28
  • [ 872-85-5 ]
  • [ 1122-62-9 ]
  • [ 112881-51-3 ]
Reference: [1] Dalton Transactions, 2012, vol. 41, # 14, p. 4255 - 4261
[2] Synlett, 2005, # 8, p. 1251 - 1254
[3] Organic and Biomolecular Chemistry, 2016, vol. 14, # 15, p. 3793 - 3808
[4] Polyhedron, 2016, vol. 103, p. 241 - 247
[5] Inorganica Chimica Acta, 2011, vol. 366, # 1, p. 134 - 140
[6] Crystal Growth and Design, 2012, vol. 12, # 8, p. 4264 - 4274
[7] Canadian Journal of Chemistry, 1991, vol. 69, # 2, p. 315 - 321
[8] Dalton Transactions, 2008, # 3, p. 386 - 396
[9] Journal of the American Chemical Society, 2011, vol. 133, # 19, p. 7509 - 7516
[10] New Journal of Chemistry, 2014, vol. 38, # 6, p. 2679 - 2685
[11] ChemPlusChem, 2014, vol. 79, # 7, p. 985 - 994
[12] New Journal of Chemistry, 2016, vol. 40, # 7, p. 5906 - 5913
[13] Monatshefte fur Chemie, 2017, vol. 148, # 5, p. 893 - 900
[14] Australian Journal of Chemistry, 2017, vol. 70, # 5, p. 494 - 498
[15] Supramolecular Chemistry, 2018, vol. 30, # 8, p. 706 - 712
  • 29
  • [ 872-85-5 ]
  • [ 112881-51-3 ]
Reference: [1] Bulletin of the Korean Chemical Society, 2011, vol. 32, # 10, p. 3566 - 3570
[2] New Journal of Chemistry, 2016, vol. 40, # 7, p. 5775 - 5781
  • 30
  • [ 872-85-5 ]
  • [ 55482-73-0 ]
  • [ 112881-51-3 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 35, p. 4023 - 4026
  • 31
  • [ 872-85-5 ]
  • [ 1397815-20-1 ]
  • [ 169555-95-7 ]
Reference: [1] Amino Acids, 2012, vol. 42, # 4, p. 1339 - 1348
  • 32
  • [ 872-85-5 ]
  • [ 24489-96-1 ]
Reference: [1] Patent: EP1489078, 2004, A1, . Location in patent: Page 183
  • 33
  • [ 872-85-5 ]
  • [ 867-13-0 ]
  • [ 24489-96-1 ]
Reference: [1] Bioorganic & Medicinal Chemistry, 2000, vol. 8, # 6, p. 1423 - 1432
[2] Chemical Communications, 2014, vol. 50, # 98, p. 15631 - 15633
  • 34
  • [ 872-85-5 ]
  • [ 21204-67-1 ]
  • [ 24489-96-1 ]
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 33, p. 7347 - 7352
  • 35
  • [ 872-85-5 ]
  • [ 197774-66-6 ]
Reference: [1] Bioorganic & Medicinal Chemistry, 2000, vol. 8, # 6, p. 1423 - 1432
  • 36
  • [ 872-85-5 ]
  • [ 619-05-6 ]
  • [ 316833-32-6 ]
Reference: [1] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 8, p. 2297 - 2304
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 872-85-5 ]

Donepezil Related Intermediates

Chemical Structure| 22065-85-6

[ 22065-85-6 ]

1-Benzylpiperidine-4-carbaldehyde

Related Functional Groups of
[ 872-85-5 ]

Aldehydes

Chemical Structure| 99163-12-9

[ 99163-12-9 ]

4-(Pyridin-4-yl)benzaldehyde

Similarity: 0.88

Chemical Structure| 176526-00-4

[ 176526-00-4 ]

2-(Pyridin-4-yl)benzaldehyde

Similarity: 0.88

Chemical Structure| 127406-55-7

[ 127406-55-7 ]

4-(Pyridin-3-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 63875-01-4

[ 63875-01-4 ]

2-Methylisonicotinaldehyde

Similarity: 0.84

Chemical Structure| 100910-66-5

[ 100910-66-5 ]

5-Methylnicotinaldehyde

Similarity: 0.83

Related Parent Nucleus of
[ 872-85-5 ]

Pyridines

Chemical Structure| 99163-12-9

[ 99163-12-9 ]

4-(Pyridin-4-yl)benzaldehyde

Similarity: 0.88

Chemical Structure| 176526-00-4

[ 176526-00-4 ]

2-(Pyridin-4-yl)benzaldehyde

Similarity: 0.88

Chemical Structure| 1122-54-9

[ 1122-54-9 ]

4-Acetylpyridine

Similarity: 0.86

Chemical Structure| 127406-55-7

[ 127406-55-7 ]

4-(Pyridin-3-yl)benzaldehyde

Similarity: 0.86

Chemical Structure| 63875-01-4

[ 63875-01-4 ]

2-Methylisonicotinaldehyde

Similarity: 0.84